SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001319244-24-000044
Filing Date
2024-05-28
Accepted
2024-05-28 16:22:37
Documents
1
Group Members
INTEGRATED CORE STRATEGIES (US) LLCISRAEL A. ENGLANDERMILLENNIUM GROUP MANAGEMENT LLCMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 ADPT_SC13G.htm SC 13G 93787
  Complete submission text file 0001319244-24-000044.txt   95742
Mailing Address C/O MILLENNIUM MANAGEMENT LLC 399 PARK AVENUE NEW YORK NY 10022
Business Address C/O MILLENNIUM MANAGEMENT LLC 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100
INTEGRATED CORE STRATEGIES (US) LLC (Filed by) CIK: 0001319244 (see all company filings)

IRS No.: 980330397 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Subject) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91363 | Film No.: 24992129
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)